RecruitingNCT00369421

Diagnosis and Treatment of Patients With Inborn Errors of Metabolism

Diagnosis and Treatment of Patients With Inborn Errors of Metabolism or Other Genetic Disorders


Sponsor

National Human Genome Research Institute (NHGRI)

Enrollment

4,000 participants

Start Date

Sep 12, 1978

Study Type

OBSERVATIONAL

Conditions

Summary

Researchers intend on diagnosing and treating certain inborn errors of metabolism. By doing this researchers hope to expand their knowledge about these disorders and provide access to patients of interest for research, teaching, and clinical experience. Patients participating in this study will be examined and treated on an out patient basis, if practical. However, patients requiring specialized tests or treatments will be admitted to the NIH Clinical Center as necessary. Researchers will use only accepted medical procedures in diagnosing (medical history, physical examinations, X-ray studies, eye examinations, blood tests, and urine tests) and treating the patients involved in this study. Additional tests may be required on a case to case basis. Many patients seen in this study will go on to be enrolled in a specific disease-related research study.\<TAB\>


Eligibility

Min Age: 1 MonthMax Age: 115 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with arterial calcification due to deficiency of cd73. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

National Institutes of Health Clinical Center

Bethesda, Maryland, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT00369421